Impact of (18)F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer. Basso Dias A, Finelli A, Bauman G, Veit-Haibach P, et al. Radiology 2022 May 24:211836. doi: 10.1148/radiol.211836.

Read + Share

Amedeo Smart

Independent Medical Education

Basso Dias A, Finelli A, Bauman G, Veit-Haibach P, et al. Impact of (18)F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer. Radiology 2022 May 24:211836. doi: 10.1148/radiol.211836.
PMID: 35608445